Table 2. Patients characteristics.
Patients | Age | Sex | Baseline diagnosis | DAC Treatments | Response to DAC therapy (after 2 cycles) |
---|---|---|---|---|---|
UPN1 | 54 | M | hepatocellular carcinoma | DAC monotherapy | SD |
UPN2 | 58 | M | hepatocellular carcinoma | PRFA combined DAC | SD |
UPN3 | 54 | F | carcinoma of uterine tube | DAC+chemotherapy | SD |
UPN4 | 42 | F | ovarian cancer | DAC+chemotherapy | PR |